Document is current

Article History

Received: 26 January 2021

Accepted: 12 May 2021

First Online: 10 August 2021

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committees (<i>Observational study:</i> Copernicus Group IRB, Tracking #20190783; <i>Clinical trial:</i> Germany (Lead): Dresden, Technische Universität Dresden. Ethikkommission an der TU Dresden; Ulm, Landesärztekammer Baden-Württemberg; Denmark (Central): MIDT regionmidtjylland; Italy (Lead): Ospedale San Raffaele, Milan; Azienda Ospedaliero-Universitaria Pisana, Pisa; Policlinico Umberto I, Roma; Policlinico S.Orsola-Malpighi, Bologna; Policlinico Universitario Campus Bio-Medico, Roma; Norway: REK (Regionale Komiteer for medisinsk og helsefaglig forskningsetikk); Canada (Central): Advarra IRB; USA (Central) Advarra IRB; BSD IRB The University of Chicago Biological Sciences Division; Columbia Research Human Research Protection Office IRB; Mayo Clinic IRB) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all respondents who participated in the study.

: Not applicable.

: M. Brod is a paid consultant to the pharmaceutical industry, including Ascendis Pharma. A. Smith, D. Markova, S. Mourya, Z. Lin, and A. Shu are employees of Ascendis Pharma, Inc. J. Gianettoni was an employee of Ascendis Pharma, Inc. when the research was conducted<b>.</b> L. McLeod is an employee of RTI Health Solutions (RTI International).